<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00738894</url>
  </required_header>
  <id_info>
    <org_study_id>HLX 06-03</org_study_id>
    <nct_id>NCT00738894</nct_id>
  </id_info>
  <brief_title>GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients</brief_title>
  <acronym>REDUCE</acronym>
  <official_title>GORE® HELEX® Septal Occluder / GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients With Patent Foramen Ovale (PFO) - The Gore REDUCE Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to determine if patent foramen ovale (PFO) closure with the GORE®
      HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder plus antiplatelet medical
      management is safe and effective and reduces the risk of recurrent stroke or
      imaging-confirmed transient ischemic attack (TIA) when compared to antiplatelet medical
      management alone in patients with a PFO and history of cryptogenic stroke or
      imaging-confirmed TIA.

      A co-primary objective is to demonstrate that medical management plus closure with the study
      device reduces the risk of new brain infarct compared to medical management alone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">May 11, 2020</completion_date>
  <primary_completion_date type="Actual">April 24, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects With Freedom From Recurrent Ischemic Stroke (Primary Outcome #1)</measure>
    <time_frame>24 months</time_frame>
    <description>A recurrent stroke event was defined as the first occurrence post-randomization of either a) neurological deficit presumed due to ischemia and persisting longer than 24 hours or until death, or b) transient neurological deficit presumed due to ischemia, persisting less than 24 hours with MRI evidence of a new relevant brain infarction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Subjects With New Brain Infarct or Recurrent Stroke (Primary Outcome #2)</measure>
    <time_frame>24 months</time_frame>
    <description>Responders were subjects who showed one or more new infarctions on MRI since screening, or experienced a confirmed recurrent stroke, through 24 months (913 days). Nonresponders were subjects who did not show new infarction on MRI since screening and were confirmed free of recurrent stroke through at least 549 days.
An infarction was defined as a new (since screening) T2 hyperintense MRI lesion with diameter ≥ 3 mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Study-related Serious Adverse Events</measure>
    <time_frame>24 months</time_frame>
    <description>Adverse event seriousness and relationship to study treatments (device, procedure, or antiplatelet medical therapy) as reported by each investigative site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With Effective Closure in Test (Device) Arm</measure>
    <time_frame>24 months</time_frame>
    <description>Assessment of PFO closure in test (device) arm subjects by transesophageal echocardiography (TEE) at 24-month follow-up.
Effective closure defined as occluded, small, or moderate shunt (0-25 bubbles).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">664</enrollment>
  <condition>Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <arm_group>
    <arm_group_label>Medical Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Antiplatelet medical therapy alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Device Closure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PFO closure with study septal occluder device plus antiplatelet medical therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Septal Occluder Device</intervention_name>
    <description>PFO closure with study septal occluder device</description>
    <arm_group_label>Device Closure</arm_group_label>
    <other_name>GORE® HELEX® Septal Occluder</other_name>
    <other_name>GORE® CARDIOFORM Septal Occluder</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiplatelet Medical Therapy</intervention_name>
    <description>Investigator's choice of one of three regimen options specified in protocol</description>
    <arm_group_label>Device Closure</arm_group_label>
    <arm_group_label>Medical Management</arm_group_label>
    <other_name>Aspirin</other_name>
    <other_name>Dipyridamole</other_name>
    <other_name>Aggrenox</other_name>
    <other_name>Clopidogrel</other_name>
    <other_name>Plavix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of cryptogenic ischemic stroke or TIA of presumed embolic infarction verified
             by a neurologist within 180 days prior to randomization

          -  Presence of Patent Foramen Ovale (PFO), as determined initially by positive bubble
             study utilizing transesophageal echocardiography (TEE), demonstrating spontaneous
             right-to-left shunting or right-to-left shunting during Valsalva maneuver.

          -  Absence of an identifiable source of thromboembolism in the systemic circulation

          -  No evidence of a hypercoagulable state

          -  Note: Additional Inclusion Criteria may apply

        Exclusion Criteria:

          -  Other co-morbidities including, but not limited to, mural thrombus, dilated
             cardiomyopathy, atrial fibrillation/flutter, cardiac prosthetics (valves), mitral
             valve stenosis, aortic dissection, significant atherosclerosis, vasculitis,
             pre-existing neurologic disorders, multiple sclerosis, arteriovenous malformations,
             prior intracranial hemorrhage, severe central nervous system (CNS) disease, severe
             disability related to prior stroke, and autoimmune disorders that would increase the
             risk of mortality or morbidity above what is typical for the treatment

          -  Previous Myocardial Infarction

          -  Active infection that cannot be treated successfully prior to randomization

          -  Sensitivity or contraindication to all proposed medical treatments

          -  Pregnancy or intent on becoming pregnant through 24-months after randomization

          -  Indications outside the parameters accepted for placement of the GORE® HELEX® Septal
             Occluder / GORE® Septal Occluder, including extensive congenital cardiac anomalies and
             defect diameter estimated to be &gt; 18mm

          -  Atrial septal anatomy that is expected to necessitate placement of more than one GORE®
             HELEX® Septal Occluder / GORE® CARDIOFORM Septal Occluder

          -  Need for concomitant procedure(s) that may confound detection of adverse events
             related to device placement

          -  Note: Additional Exclusion Criteria may apply
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott E. Kasner, MD, FAHA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John F. Rhodes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lars Søndergaard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 19, 2008</study_first_submitted>
  <study_first_submitted_qc>August 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2008</study_first_posted>
  <results_first_submitted>May 16, 2018</results_first_submitted>
  <results_first_submitted_qc>July 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 9, 2018</results_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cryptogenic</keyword>
  <keyword>stroke</keyword>
  <keyword>transient ischemic attack</keyword>
  <keyword>TIA</keyword>
  <keyword>PFO</keyword>
  <keyword>Patent foramen ovale</keyword>
  <keyword>HELEX</keyword>
  <keyword>Septal Occluder</keyword>
  <keyword>PFO Occluder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Dipyridamole</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 15, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT00738894/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 15, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/94/NCT00738894/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Device Closure</title>
          <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
        <group group_id="P2">
          <title>Medical Management</title>
          <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="441"/>
                <participants group_id="P2" count="223"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="402"/>
                <participants group_id="P2" count="190"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Device Closure</title>
          <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
        <group group_id="B2">
          <title>Medical Management</title>
          <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="441"/>
            <count group_id="B2" value="223"/>
            <count group_id="B3" value="664"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.4" spread="9.3"/>
                    <measurement group_id="B2" value="44.8" spread="9.6"/>
                    <measurement group_id="B3" value="45.2" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="180"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="265"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="261"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="399"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="413"/>
                    <measurement group_id="B2" value="213"/>
                    <measurement group_id="B3" value="626"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="412"/>
                    <measurement group_id="B2" value="203"/>
                    <measurement group_id="B3" value="615"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="216"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="331"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time from qualifying event to randomization</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100" spread="52"/>
                    <measurement group_id="B2" value="101" spread="53"/>
                    <measurement group_id="B3" value="101" spread="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current smoking</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="58"/>
                    <measurement group_id="B3" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes mellitus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke or TIA before index event</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Previous either</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous stroke</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous TIA</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Index event</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="441"/>
                    <count group_id="B2" value="223"/>
                    <count group_id="B3" value="664"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Stroke w/ symptoms &gt;=24 hr</title>
                  <measurement_list>
                    <measurement group_id="B1" value="402"/>
                    <measurement group_id="B2" value="199"/>
                    <measurement group_id="B3" value="601"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stroke symptoms &lt;24 hr, w/ imaging confirmation</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Patent foramen ovale shunt size</title>
          <population>16 device closure subjects and 7 medical management subjects reported shunt assessment of unknown, unable to perform, or not performed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="425"/>
                    <count group_id="B2" value="216"/>
                    <count group_id="B3" value="641"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Small (1-5 bubbles)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate (6-25 bubbles)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="166"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Large (&gt;25 bubbles)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="182"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="261"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Atrial septal aneurysm</title>
          <population>Atrial septal aneurysm was determined during the PFO closure procedure; it was not recorded for any medical management subjects, nor for 19 of the 28 device closure subjects with no study device implant attempt.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="422"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="422"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With Freedom From Recurrent Ischemic Stroke (Primary Outcome #1)</title>
        <description>A recurrent stroke event was defined as the first occurrence post-randomization of either a) neurological deficit presumed due to ischemia and persisting longer than 24 hours or until death, or b) transient neurological deficit presumed due to ischemia, persisting less than 24 hours with MRI evidence of a new relevant brain infarction.</description>
        <time_frame>24 months</time_frame>
        <population>Intention to Treat: includes all subjects randomized</population>
        <group_list>
          <group group_id="O1">
            <title>Device Closure</title>
            <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
          <group group_id="O2">
            <title>Medical Management</title>
            <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Freedom From Recurrent Ischemic Stroke (Primary Outcome #1)</title>
          <description>A recurrent stroke event was defined as the first occurrence post-randomization of either a) neurological deficit presumed due to ischemia and persisting longer than 24 hours or until death, or b) transient neurological deficit presumed due to ischemia, persisting less than 24 hours with MRI evidence of a new relevant brain infarction.</description>
          <population>Intention to Treat: includes all subjects randomized</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="441"/>
                <count group_id="O2" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Test null hypothesis of equal or lower recurrent stroke-free survivorship for device closure compared to medical management.
H0: Sd(t) ≤ Sm(t) for all t, versus H1: Sd(t) &gt; Sm(t) for all t, where Sd(t) and Sm(t) are true Kaplan-Meier product-limit survivor functions for the device closure and medical management arms and t is time from randomization to event or censoring.
Event-free subjects were censored at time of last follow-up. Significance threshold (1-sided alpha) = 0.025.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>This is the first of two primary outcomes for this study. Assumptions for power calculations: expected event free for medical management 92% at 24 months; expected event free for device closure 96.4% at 24 months (55% risk reduction); 664 subjects randomly assigned 2:1 to device closure or medical management provides 80% power with 15% attrition (over 5 years) and 1-sided alpha = 0.024 to allow for interim analysis (interim analysis later rescinded from plan).</non_inferiority_desc>
            <p_value>0.001</p_value>
            <p_value_desc>1-sided p-value was adjusted for multiplicity with 2nd primary outcome using Dubey and Armitage-Parmer (D/AP) procedure.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.09</ci_lower_limit>
            <ci_upper_limit>0.62</ci_upper_limit>
            <estimate_desc>Hazard ratio (test/control) obtained from Cox proportional hazards model with treatment arm as sole explanatory variable, the exponentiated coefficient of which provided the hazard ratio. Unadjusted for multiplicity.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Subjects With New Brain Infarct or Recurrent Stroke (Primary Outcome #2)</title>
        <description>Responders were subjects who showed one or more new infarctions on MRI since screening, or experienced a confirmed recurrent stroke, through 24 months (913 days). Nonresponders were subjects who did not show new infarction on MRI since screening and were confirmed free of recurrent stroke through at least 549 days.
An infarction was defined as a new (since screening) T2 hyperintense MRI lesion with diameter ≥ 3 mm.</description>
        <time_frame>24 months</time_frame>
        <population>Intention to Treat: includes all subjects randomized and evaluated for brain infarct</population>
        <group_list>
          <group group_id="O1">
            <title>Device Closure</title>
            <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
          <group group_id="O2">
            <title>Medical Management</title>
            <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With New Brain Infarct or Recurrent Stroke (Primary Outcome #2)</title>
          <description>Responders were subjects who showed one or more new infarctions on MRI since screening, or experienced a confirmed recurrent stroke, through 24 months (913 days). Nonresponders were subjects who did not show new infarction on MRI since screening and were confirmed free of recurrent stroke through at least 549 days.
An infarction was defined as a new (since screening) T2 hyperintense MRI lesion with diameter ≥ 3 mm.</description>
          <population>Intention to Treat: includes all subjects randomized and evaluated for brain infarct</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="383"/>
                <count group_id="O2" value="177"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Test null hypothesis of equal or higher proportion with brain infarct for device closure compared to medical management.
H0: Pm - Pd ≤ 0, versus H1: Pm - Pd &gt; 0, where Pd and Pm are true proportions of subjects with brain infarct for the device closure and medical management arms.
Significance threshold (1-sided alpha) = 0.025.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>This is the second of two primary outcomes for this study. Assumptions for power calculations: expected proportion of brain infarct is 3-7 times the clinical stroke rate; expected brain infarct proportion for medical management 14.5% (2.9% clinical stroke x 5); expected brain infarct for device closure 6.5% (55% risk reduction); 597 subjects (10% attrition from 664) provides 73% power with 1-sided alpha = 0.0125 (based conservatively on a Bonferroni adjustment of alpha/2).</non_inferiority_desc>
            <p_value>0.024</p_value>
            <p_value_desc>1-sided p-value was adjusted for multiplicity with 1st primary outcome using Dubey and Armitage-Parmer (D/AP) procedure.</p_value_desc>
            <method>z-test, 1-sided</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.056</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.003</ci_lower_limit>
            <ci_upper_limit>0.108</ci_upper_limit>
            <estimate_desc>Unadjusted for multiplicity.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Study-related Serious Adverse Events</title>
        <description>Adverse event seriousness and relationship to study treatments (device, procedure, or antiplatelet medical therapy) as reported by each investigative site</description>
        <time_frame>24 months</time_frame>
        <population>Intention to Treat: all subjects randomized</population>
        <group_list>
          <group group_id="O1">
            <title>Device Closure</title>
            <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
          <group group_id="O2">
            <title>Medical Management</title>
            <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Study-related Serious Adverse Events</title>
          <description>Adverse event seriousness and relationship to study treatments (device, procedure, or antiplatelet medical therapy) as reported by each investigative site</description>
          <population>Intention to Treat: all subjects randomized</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="441"/>
                <count group_id="O2" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With Effective Closure in Test (Device) Arm</title>
        <description>Assessment of PFO closure in test (device) arm subjects by transesophageal echocardiography (TEE) at 24-month follow-up.
Effective closure defined as occluded, small, or moderate shunt (0-25 bubbles).</description>
        <time_frame>24 months</time_frame>
        <population>All subjects randomized to test (device) arm with 24-month PFO closure assessment</population>
        <group_list>
          <group group_id="O1">
            <title>Device Closure</title>
            <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With Effective Closure in Test (Device) Arm</title>
          <description>Assessment of PFO closure in test (device) arm subjects by transesophageal echocardiography (TEE) at 24-month follow-up.
Effective closure defined as occluded, small, or moderate shunt (0-25 bubbles).</description>
          <population>All subjects randomized to test (device) arm with 24-month PFO closure assessment</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="318"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="312"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Device Closure</title>
          <description>PFO closure with study septal occluder device plus antiplatelet medical therapy
Septal Occluder Device: GORE® HELEX® Septal Occluder or GORE® CARDIOFORM Septal Occluder
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
        <group group_id="E2">
          <title>Medical Management</title>
          <description>Antiplatelet medical therapy alone
Antiplatelet Medical Therapy: Investigator's choice of one of three regimen options specified in protocol</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (20.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="102" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pericardial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Complication of device removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Campylobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chronic tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Renal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Streptococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Viral pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Postoperative fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Compartment syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Neck mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Carotid artery dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diabetic hyperosmolar coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dural arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thunderclap headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ulnar tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vertebral artery dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Mania</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Calculus urethral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urethral meatus stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysfunctional uterine bleeding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ovarian cyst ruptured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Osteosynthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vena cava thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (20.1)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="324" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="154" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Increased tendency to bruise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lymphocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cardiac discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Postural orthostatic tachycardia syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Developmental hip dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pulmonary arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cerumen impaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cupulolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eustachian tube disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tympanic membrane hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Blindness transient</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Conjunctival haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Mydriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abnormal sensation in eye</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dry eye</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Iritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Keratitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lens disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ocular discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ocular hyperaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Scleritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abdominal wall cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Change of bowel habit</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Colitis microscopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oesophageal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oesophageal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oral dysaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pharyngo-oesophageal diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rectal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Feeling hot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Puncture site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Suprapubic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Temperature intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vessel puncture site bruise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypertransaminasaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chronic tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Onychomycosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tinea pedis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Viral labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cytomegalovirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Epstein-Barr virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Groin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Helicobacter infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Infectious mononucleosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oral viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Perichondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tinea cruris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Incision site complication</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cartilage injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Epicondylitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Animal scratch</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Endotracheal intubation complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Exposure to body fluid</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Limb traumatic amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Persistent corneal epithelial defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Post-traumatic neck syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Blood magnesium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Grip strength decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Platelet count increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Iron deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abnormal loss of weight</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Abnormal weight gain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyperhomocysteinaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Postprandial hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Groin pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Limb discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Inguinal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Jaw disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myalgia intercostal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Myokymia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Polymyalgia rheumatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rheumatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sjogren's syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Acoustic neuroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Eye naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haemangioma of liver</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Amimia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Aura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Clumsiness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Exertional headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Fine motor skill dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Focal dyscognitive seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Head discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Morton's neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Muscle spasticity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Occipital neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pineal gland cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Quadrantanopia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Subdural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ulnar neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Upper motor neurone lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Gestational hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Post stroke depression</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Affect lability</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sleep disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Attention deficit/hyperactivity disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Agitated depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Drug abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Executive dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Somnambulism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urine abnormality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Breast pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Adnexa uteri mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Amenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Endometrial disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Menopausal symptoms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pelvic discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Polycystic ovaries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Premenstrual dysphoric disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Testicular mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Testicular pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Asthma exercise induced</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Nasal turbinate hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Paranasal sinus mucosal hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Sinus pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rosacea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Chloasma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hand dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Ingrowing nail</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pemphigus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Precancerous skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Pustular psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Seborrhoeic dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin depigmentation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Dental disorder prophylaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Essential hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Labile hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="223"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="441"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="223"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of results requires review and approval by REDUCE Publication and Presentation Committee</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Bryan Randall</name_or_title>
      <organization>W. L. Gore &amp; Associates</organization>
      <phone>928-864-4832</phone>
      <email>BRandall@WLGore.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

